Stock Code: Guangzhou Improve Medical Instruments Co.Ltd(300030) stock abbreviation: Guangzhou Improve Medical Instruments Co.Ltd(300030) Announcement No.: 2022018 bond Code: 112522 bond abbreviation: 17 Yangpu S1
Guangzhou Improve Medical Instruments Co.Ltd(300030) Technology Co., Ltd
Announcement on the forecast of daily connected transactions in 2022
The company and all members of its board of directors guarantee that the contents of the announcement are true, accurate and complete without false records, misleading statements or major omissions.
1、 Basic information of daily connected transactions
1. Overview of related party transactions
On April 21, 2022, Guangzhou Improve Medical Instruments Co.Ltd(300030) Technology Co., Ltd. (hereinafter referred to as “the company”) held the 17th meeting of the 5th board of directors and the 13th meeting of the 5th board of supervisors, deliberated and adopted the proposal on the prediction of daily connected transactions in 2022. The total amount of daily transactions between Sinovel and Guangzhou Sinovel Technology Co., Ltd. (hereinafter referred to as “Sinovel”) is not expected to exceed RMB 2022 million, and the total amount of daily transactions between Sinovel and Guangzhou Sinovel Technology Co., Ltd. (hereinafter referred to as “Sinovel”) does not exceed RMB 2022 million The total amount of daily related party transactions with Guangzhou Yibo Information Technology Co., Ltd. (hereinafter referred to as “Guangzhou Yibo”) shall not exceed 8.3 million yuan, and the total amount of daily related party transactions with Zhuhai Gree Group Co., Ltd. (hereinafter referred to as “Gree Group”) shall not exceed 6.2 million yuan. The independent directors of the company expressed their consent. The proposal is within the deliberation authority of the board of directors of the company and does not need to be submitted to the general meeting of shareholders for deliberation.
2. Estimated type and amount of related party transactions
The company has estimated the daily related party transactions of Kangdai Sirui, Anfang biology, Guangzhou Yibo and Gree Group in 2022. The details are as follows:
Unit: Yuan
Related party related party transactions the estimated amount of related party transactions in 2022 has been paid as of the disclosure date, the amount of the previous year, the content of the pricing principle, and the amount generated
Kangdai Sirui accepts the labor market pricing of 100000000 0.0035346534
The market price of biological purchased goods of Anfang is 1000000000 0.00357522126
The labor market price of Guangzhou Medical Expo is 83000000 0.00507116368
Gree Group’s rental housing market price is 6200 Shenzhen Quanxinhao Co.Ltd(000007) 2430092465044040 and buildings
Total 25500 Shenzhen Quanxinhao Co.Ltd(000007) 24 Nova Technology Corporation Limited(300921) 365029068
3. Actual occurrence of daily related party transactions in the previous year
Unit: Yuan
Related party transactions in 2021 actual 2021 expected 2021 actual 2021 actual amount of related party content in 2021 proportion of similar amount to expected business amount difference (%)
Shenzhen Yikang
Tailai technology has received 112 labor services, 200728 3.96%
Limited company
1200000000 – 54.92% Guangzhou hanghuasheng
Physical medicine technology receives labor 428786175 15.15%
Guangzhou hanghuasheng Co., Ltd
Guangzhou hanghuasheng Pharmaceutical Technology Co., Ltd. sells goods 88507374500000000 0.11% – 82.3%
Provision of labor services by Wu pharmaceutical technology 385.00 — Co., Ltd
Products purchased by Anfang biology 3575221261100000000 1.15% – 67.50%
Guangzhou Medical Expo provides labor services 507116368700000000 7.22% – 27.55%
Guangzhou Medical Expo receives labor services 63672566 – 2.25%-
Kangdai Sirui purchased goods 221039061 – 0.71%-
Kang Dai Sirui accepts labor 35346534 – 1.25%-
Gree Group house leasing 465044040 – 35.72%-
Hangzhou longxinke purchased goods 149652137 – 0.48% – Technology Co., Ltd
Hangzhou longxinke selling goods 10729204 – 0.01% – Technology Co., Ltd
Shenzhen Shangwei
Products sold by Hi Tech Co., Ltd. 1769911 – 0.002% – Company Dian Diagnostics Group Co.Ltd(300244) Technology
The sale of goods by the technology group 5803359 – 0.01% – the board of directors of the Company Limited and its subsidiaries estimated the annual daily connected transactions between the company and the connected parties based on the company’s actual needs and the preliminary judgment of the actual situation and expected existence and development of the business, so there is a certain difference from the actual situation, If the actual total amount of daily related party transactions in 2021 is lower than the expected total amount, it belongs to the normal operation behavior, which will not have a significant impact on the daily operation and performance of the company.
Note: Guangzhou HANGHUA Biomedical Technology Co., Ltd. is a subsidiary of Shenzhen yikangtailai Technology Co., Ltd.
2、 Basic information of related parties
(I) Guangzhou Anfang Biotechnology Co., Ltd
1. Basic biological information of Angola
Legal representative: Han Chao
Registered capital: 103535 yuan
Main business: technology import and export; Research and development of human body science; Research and development of health science projects; Research and development of stem cell technology; Natural science research and experimental development; Medical research and experimental development; Biotechnology consultation and exchange services; Import and export of goods (except for goods exclusively controlled by franchises); Sales of biological diagnostic reagents and kits (excluding license approval items); Sales of biological products (excluding licensed business projects); Commodity wholesale trade (except for licensed and approved commodities); Trade agency; Wholesale of chemical products (excluding hazardous chemicals); Operation of non licensed medical devices; Retail of medical supplies and equipment (excluding drugs and medical devices); Wholesale of office equipment and consumables; Manufacturing of special equipment for daily sundry production; Sell the products produced by the company (except for the items prohibited by national laws and regulations; the products involving licensed operation can be operated only after obtaining the license); Wholesale of medical diagnosis, monitoring and treatment equipment; Wholesale of biological products (excluding vaccines); Production of medical electronic instruments and equipment (the specific production scope shall be subject to the medical device manufacturing enterprise license)
Address: room 239251, 2nd floor above ground, North Tower, Hejing Xinghui Plaza, No. 36 and 38, Huanyu Third Road, Guangzhou International Biological Island
Financial situation: as of December 31, 2021, the total assets were 9.0471 million yuan, the net assets were 7.2538 million yuan, the operating income in 2021 was 4.9599 million yuan, and the net profit was -4.5309 million yuan. (this data has not been audited) 2. Relationship with listed companies
Anfang biology is a joint-stock company of the company, and the company holds 7% of its equity.
3. Performance analysis
Anfang bio continues to operate in accordance with the law, has normal production and operation, and has a stable cooperative relationship with the company. This related party transaction is required for normal operation, and there is no risk of failure to perform.
(II) Hangzhou Kangdai Sirui Biotechnology Co., Ltd
1. Basic information of Kangdai Sirui
Legal representative: Xiaojun Lei
Registered capital: 147403 million yuan
Main business: research and development of biochemical product technology; Research, development and application of cell technology; Research and development of industrial enzyme preparation; Production of class I medical devices; Sales of class I medical devices; Sales of class II medical devices; Import and export of goods; Software development; Technical services, technical development, technical consultation, technical exchange, technology transfer and technology promotion (except for projects that must be approved according to law, business activities shall be carried out independently according to law with business license). Licensed items: production of class II medical devices; Class III medical device business; Class III medical device production (for items that must be approved according to law, business activities can be carried out only after being approved by relevant departments, and the specific business items shall be subject to the approval results)
Address: Room 201, building 47, No. 488-1, Donghu North Road, Donghu street, Linping District, Hangzhou, Zhejiang Province
Financial situation: as of December 31, 2021, the total assets were 246744 million yuan, the net assets were 206612 million yuan, the operating income in 2021 was 4.9148 million yuan, and the net profit was -4.7315 million yuan. (this data has not been audited) 2. Relationship with listed companies
Kangdai Sirui is a joint-stock company of the company, and the company holds 29.918% of its equity.
3. Performance analysis
Kangdai Sirui continues to operate according to law. The company has normal production and operation and good financial condition. This related party transaction is required for normal operation, and there is no risk of failure to perform normally.
(III) Guangzhou Yibo Information Technology Co., Ltd
1. Basic information of Guangzhou Medical Expo
Legal representative: Zhang Zhiqiang
Registered capital: 5.01 million yuan
Main business: software development; Software services; Software wholesale; Software retail; Information and electronic technology services; Information technology consulting services; Commodity information consulting services; Scientific and technological information consulting services; Data processing and storage services; Research and development of network technology; Computer technology development and technical services; Information system integration service; Technology import and export; Computer wholesale; Computer retail; Wholesale of computer spare parts; Retail of computer spare parts; Wholesale of communication equipment and supporting equipment; Wholesale of communication terminal equipment; Retail of communication equipment; Wholesale of electronic components; Retail of electronic components; Wholesale of electronic products; Retail of electronic products; Wholesale of office equipment; Wholesale of office equipment and consumables; Retail of office equipment consumables
Address: 401d, No. 7, caipin Road, Science City, Guangzhou Economic and Technological Development Zone
Financial situation (audited): as of December 31, 2021, the total assets were 234808 million yuan, the net assets were -151724 million yuan, the operating income in 2021 was 187872 million yuan, and the net profit was -2.8123 million yuan. 2. Relationship with listed companies
Guangzhou Yibo is a joint-stock company of the company, and the company holds 40% of its equity.
3. Performance analysis
Guangzhou Medical EXPO continues to operate according to law, with normal production and operation and stable cooperative relationship with the company. This related party transaction is required for normal operation and there is no risk of failure to perform.
(IV) Zhuhai Gree Group Co., Ltd
1. Basic information of Gree
Legal representative: Zhou Lewei
Registered capital: RMB 80 million
Main business: manufacturing of household electric appliances; Investment, construction and operation management of public facilities and municipal facilities; Hotel investment, construction and operation management; Operation, investment and management of state-owned assets; Optimizing the allocation of state-owned assets and capital operation; Transfer and lease of state-owned property rights; Enterprise management, planning and service; Income management of state-owned assets; Business services (excluding licensed business projects) (for projects that must be approved according to law, business activities can be carried out only with the approval of relevant departments)
Address: 2F, Hengqin wharf passenger transport center, Hengqin new area, Zhuhai
Financial situation:
(1) As of January 2020
